Delivery Order SPE2DB22D3501-SPE2DB25FUU57
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order has a ceiling value of $8,026.53 with a firm fixed price structure and an ultimate completion date of September 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $8,026.53 and an ultimate completion date of September 17, 2025. The contract involves no set-aside designation and was competitively awarded. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as both the place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $4,418.06 to AmerisourceBergen Drug Corp for the supply of Promacta 25 mg tablets in quantities of 30 units. This competitive, non-set-aside contract carries a firm fixed price structure and a completion date of September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $16,053.06, represents a non-set-aside competitive award with an ultimate completion date of September 22, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $24,059.26 and utilizes firm fixed pricing with an ultimate completion date of September 10, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a $4,418.06 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 units. This is a firm fixed price contract with no set-aside designation, utilizing competitive procurement procedures. The contract is scheduled for ultimate completion on June 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $4,418.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Promacta 25 mg tablets (30-count units). The contract, which is a child delivery order under a larger indefinite delivery vehicle, carries an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 units. This contract, valued at $17,672.24, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The ultimate completion date is set for September 30, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $26,503.50 to AmerisourceBergen Drug Corp for the supply of Promacta 12.5 mg tablets in quantities of 30 units. This firm fixed price contract, awarded on May 22, 2025, with an ultimate completion date of June 13, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,418.06 and an ultimate completion date of September 4, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FUU57Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 5, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 units. The contract is valued at $4,418.06 with a firm fixed-price structure and an ultimate completion date of March 26, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the agency. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills federal medical procurement requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's consistent performance on competitively awarded contracts demonstrates its capability to meet rigorous federal procurement standards for critical pharmaceutical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 3/5/25 |